Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.50
-0.45 (-1.33%)
Aug 15, 2025, 1:57 PM CST

TPEX:7427 Statistics

Total Valuation

TPEX:7427 has a market cap or net worth of TWD 1.46 billion. The enterprise value is 972.58 million.

Market Cap1.46B
Enterprise Value 972.58M

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

TPEX:7427 has 43.64 million shares outstanding. The number of shares has increased by 12.60% in one year.

Current Share Class 43.64M
Shares Outstanding 43.64M
Shares Change (YoY) +12.60%
Shares Change (QoQ) +12.32%
Owned by Insiders (%) 9.92%
Owned by Institutions (%) n/a
Float 37.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 822.15
PB Ratio 2.60
P/TBV Ratio 2.72
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -11.08
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -12.21

Financial Position

The company has a current ratio of 30.32, with a Debt / Equity ratio of 0.02.

Current Ratio 30.32
Quick Ratio 28.91
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF -0.11
Interest Coverage -809.38

Financial Efficiency

Return on equity (ROE) is -14.21% and return on invested capital (ROIC) is -9.11%.

Return on Equity (ROE) -14.21%
Return on Assets (ROA) -8.88%
Return on Invested Capital (ROIC) -9.11%
Return on Capital Employed (ROCE) -16.05%
Revenue Per Employee 98,944
Profits Per Employee -4.88M
Employee Count18
Asset Turnover 0.00
Inventory Turnover 0.24

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -16.25% in the last 52 weeks. The beta is -0.07, so TPEX:7427's price volatility has been lower than the market average.

Beta (5Y) -0.07
52-Week Price Change -16.25%
50-Day Moving Average 35.88
200-Day Moving Average 37.42
Relative Strength Index (RSI) 36.68
Average Volume (20 Days) 104,069

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TPEX:7427 had revenue of TWD 1.78 million and -87.75 million in losses. Loss per share was -2.03.

Revenue1.78M
Gross Profit 1.07M
Operating Income -91.46M
Pretax Income -87.75M
Net Income -87.75M
EBITDA -86.65M
EBIT -91.46M
Loss Per Share -2.03
Full Income Statement

Balance Sheet

The company has 500.57 million in cash and 8.91 million in debt, giving a net cash position of 491.66 million or 11.27 per share.

Cash & Cash Equivalents 500.57M
Total Debt 8.91M
Net Cash 491.66M
Net Cash Per Share 11.27
Equity (Book Value) 563.86M
Book Value Per Share 13.09
Working Capital 508.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -79.56 million and capital expenditures -99,000, giving a free cash flow of -79.66 million.

Operating Cash Flow -79.56M
Capital Expenditures -99,000
Free Cash Flow -79.66M
FCF Per Share -1.83
Full Cash Flow Statement

Margins

Gross Margin 59.80%
Operating Margin -5,135.32%
Pretax Margin -4,927.12%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TPEX:7427 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.60%
Shareholder Yield n/a
Earnings Yield -5.99%
FCF Yield -5.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3